CentralCharts: Supercharge your portfolio with groundbreaking tools.

AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! PR Newswire NEW YORK, May 1, 2024 NEW YORK , May 1, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Akero Therapeutics, Inc. ("Akero" or "the Company") (NASDAQ: AKRO) and certain of its...

EDMONTON, Alberta, May 01, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Company" or "Regenx") (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3) announces that, further to its April 12, 2024 and April 26, 2024 news releases, a management cease trade order (the “MCTO”) has been granted by its principal regulator, the Alberta Securities ‎Commission. As previously announced on April 12, 2024, the Corporation applied for the MCTO due to an expected delay in the filing of the audited annual...

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology PR Newswire TOKYO and SAN DIEGO, May 1, 2024 - Leverages Poseida's proprietary allogeneic CAR-T platform to develop innovative convertibleCAR ® programs targeting solid tumors - TOKYO and SAN DIEGO , May 1, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") and Poseida Therapeutics, Inc. (NASDAQ: PSTX,...

VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (" CLC " or the " Company ") (CSE: CLC) is providing an update with respect to the expected timeline for filing its audited financial statements for the fiscal year ended November 30, 2023, the related management's discussion and analysis and certificates of its CEO and CFO (collectively, the "Required Documents") and its previously announced management cease trade order ("MCTO") issued by the Company's...

Levers the existing Infinite Loop™ technology to target undersupplied US$28 billion market for DMT and MEG High projected returns based on total capital investment of approximately US$165 million, favourable industry pricing and low operating cost environment Construction of the facility is expected to be complete at the end of 2026 with commercial operations commencing in early 2027 MONTREAL, QC / ACCESSWIRE / May 1, 2024 / Loop Industries, Inc. (NASDAQ:LOOP) (the "Company" or "Loop"), a...

ST. JOHN'S NEWFOUNDLAND AND LABRADOR / ACCESSWIRE / May 1, 2024 / Atlas Salt Inc. ("Atlas" or the "Company")(TSXV:SALT)(OTCQB:REMRF) announces the filing of an amended technical report (the "Amended Technical Report") for the Great Atlantic Salt Project (the "Project"), following a routine continuous disclosure review by staff of the British Columbia Securities Commission. The Company previously filed a technical report titled "Technical Report on the Great Atlantic Salt Project, Newfoundland...

Nick Twidale joins ATFX as Chief Market Analyst PR Newswire SYDNEY, May 2, 2024 SYDNEY , May 2, 2024 /PRNewswire/ -- ATFX, a leading global online trading broker, is pleased to announce that Nick Twidale has joined the company as Chief Market Analyst for the Australia region. With over two decades of experience in banking and broking, Nick brings a wealth of expertise and leadership to his new role. Nick is a highly recognisable figure in the financial services industry. As the previous APAC CEO...

New York, New York--(Newsfile Corp. - May 1, 2024) - Columbia Venture Community is presenting an exclusive series on Investing in Sports, starting with a panel event in New York City. This event will feature former professional and Olympic athletes alongside top investors to discuss the dynamic world of sports investing and the transition challenges athletes face post-retirement. The first event will be held at Maxwell Tribeca, a new members-only social club in New York. Panelists include Author...